Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
The World Bank, USAID and the Global Financing Facility (GFF), will host the 7th Annual Health Financing Forum (AHFF7) on April 15 to 17, 2024, on the sidelines of the 2024 World Bank/IMF spring meetings.
This Catalog allows practitioners to consider which interventions have more robust evidence bases to support their practical application, such as: enhancing worker and supervisor competencies through training, offering nonfinancial incentives for high performers, practicing task sharing to promote cost savings, implementing digital solutions to expand access to services, and reducing costs of procuring and distributing pharmaceutical products.
This primer is designed to help supply chain practitioners in governments, the private sector, donor agencies, and implementing partners understand the value of political economy analysis (PEA) and how it can help improve outcomes when implementing supply chain interventions and reforms.
Join us to learn how thinking and working politically and using political economy analysis or PEA can strengthen efforts to reform health commodity supply chains.
This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.
Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.
HMED software will improve Vietnam’s capacity to effectively forecast ARV demand, and manage the drugs when they are in the country. Also, engaging drug manufacturers and distributors is crucial to overcoming supply side obstacles.
By now, much has been written about the egregious global inequities in COVID-19 vaccine distribution. But less has been said about another inequity that holds serious implications for global health: the disparities in genomic sequencing capacities and capabilities worldwide.
The events of the past 18 months underscore the importance of generally strong, equitable, and accessible health systems. COVID-19 is not the only threat we face, and as we prepare for the future it is critical that we begin to sufficiently invest in the foundational health system strengthening required to develop lasting resilience.